Michael R. McKellar, BA
Advertisement
Articles by Michael R. McKellar, BA
This commentary discusses why antibiotics and the treatment of infectious diseases present a special case for pharmaceutical development, pricing, and appropriate utilization.
Advertisement
Latest Updated Articles
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: April 23rd 2014 | Updated:
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: March 18th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Top 5 Most-Read Vaccine Content in 2025
3
Sleep Apnea Risk Tied to 40% Higher Odds of Poor Mental Health
4
Evidence Suggests Bidirectional Risk Between Ovarian, Colorectal Cancers
5
